Pilot detection study of alpha1 antitrypsin deficiency in a targeted population

American Journal of Medical Genetics

Volumn 103, Issue 1, 2001, Pages 69-74

  Fleming, Lora E ^a   Oquendo, Sarah ^a   Bean, Judy A ^a   Tamer, Robert ^a   Finn, Symma ^a   Wanner, Adam ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Genetic testing; Pulmonary disease; Self administered testing

Indexed keywords

ALPHA 1 ANTITRYPSIN;

ADULT; ALPHA 1 ANTITRYPSIN DEFICIENCY; ARTICLE; BLOOD ANALYSIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; DOCTOR PATIENT RELATION; FEMALE; GENETIC SCREENING; HIGH RISK POPULATION; HUMAN; INTERMETHOD COMPARISON; MALE; PATIENT EDUCATION; PRIORITY JOURNAL; SELF EVALUATION;

ADULT; ALPHA 1-ANTITRYPSIN; BRONCHIECTASIS; BRONCHITIS; CHRONIC DISEASE; EMPHYSEMA; FEMALE; GENETIC SCREENING; HETEROZYGOTE; HOMOZYGOTE; HUMANS; LUNG DISEASES, OBSTRUCTIVE; MALE; MIDDLE AGED; PILOT PROJECTS;

EID: 0035885239     PISSN: 01487299     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajmg.1507     Document Type: Article

References (19)

1. A registry of patients with severe deficiency of AAT
2. AAT in nonsmokers
3. Clinical features and history of the destructive lung disease associated with AAT of adults with pulmonary symptoms
4. Guidelines for the approach to the patient with severe hereditary AAT
5. Estimation of the incidence of a rare genetic disease through a two-tier mutation survey
6. 1 protease inhibitor in bronchial asthma: Phenotypes and biochemical characteristics
7. Smoking, lung function, and AAT
8. Involving consumers in the development of an educational program for cystic fibrosis carrier screening
9. Neonatal screening for AAT
10. AAT: High prevalence in the St. Louis area determined by direct population screening
11. Molecular confirmation of AAT genotypes in newborn dried blood specimens
12. Liver disease in AAT detected by screening of 200, 000 infants
13. The introduction of Cystic Fibrosis Carrier Screening into clinical practice: Policy considerations
14. Lung function, smoking and survival in severe AAT, PiZZ